Literature DB >> 17460312

Pneumonia observational incidence and treatment: a multidisciplinary process improvement study.

Jan Brozek1, Ellen McDonald, France Clarke, Carolyn Gosse, Roman Jaeschke, Deborah Cook.   

Abstract

BACKGROUND: Little information is available on the types, causes, and treatment of pneumonia in intensive care unit patients in usual clinical practice.
OBJECTIVE: To characterize treatment of patients with presumed pneumonia in a tertiary care intensive care unit and to identify potential areas for improvement in care.
METHODS: In a prospective, cohort study, the sample consisted of all consecutive patients treated in an intensive care unit during a 3-month period. For patients with presumed pneumonia, data were collected on incidence of pneumonia, diagnostic investigations, microbial isolates, and antibiotics prescribed.
RESULTS: Of 194 admissions, 73 patients were treated for pneumonia: 47 had community-acquired pneumonia; 12 had hospital-acquired pneumonia; 12 had ventilator-associated pneumonia, both early (7) and late (5); and 2 had intensive care unit-acquired pneumonia. Approximately 71% of patients had microbiological tests performed. Among 54 microbial isolates, 51.9% were gram-positive bacteria, 31.5% were gram-negative bacteria, and 9.3% were Candida species. The most commonly used antimicrobials were quinolones (54 of 192 prescriptions) and cephalosporins (33); each patient received a median of 3 antibiotics.
CONCLUSIONS: Most cases of pneumonia were community acquired. The most common causative organisms were gram-positive cocci. Four quality improvement strategies were rationalization of antibiotic use during rounds, nurses' reporting of culture results, review of antibiotic appropriateness by a pharmacist, and redesign of the clinical information system.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17460312

Source DB:  PubMed          Journal:  Am J Crit Care        ISSN: 1062-3264            Impact factor:   2.228


  1 in total

1.  A one-year prospective study of infectious etiology in patients hospitalized with acute exacerbations of COPD and concomitant pneumonia.

Authors:  Fanny W S Ko; Margaret Ip; Paul K S Chan; Susanna S S Ng; S S Chau; David S C Hui
Journal:  Respir Med       Date:  2008-06-24       Impact factor: 3.415

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.